The role of life events and HPA axis in anxiety disorders: A review

Current Pharmaceutical Design

Volumn 18, Issue 35, 2012, Pages 5663-5674

  Faravelli, Carlo ^a   Lo Sauro, Carolina ^a   Lelli, Lorenzo ^b   Pietrini, Francesco ^b   Lazzeretti, Lisa ^b   Godini, Lucia ^b   Benni, Laura ^b   Fioravanti, Giulia ^a   Talamba, Gabriela Alina ^b   Castellini, Giovanni ^b   Ricca, Valdo ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Animal models; Anxiety disorders; Childhood traumata; Cortisol; Hypothalamic pituitary adrenal axis; Life events; Stress response; Vulnerability

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ACUTE STRESS; ADAPTIVE BEHAVIOR; ADENOHYPOPHYSIS; ADRENERGIC SYSTEM; AMYGDALOID NUCLEUS; ANXIETY DISORDER; CHILD ABUSE; CHRONIC STRESS; CORTICOTROPIN RELEASE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENERALIZED ANXIETY DISORDER; HOLOCAUST; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFE EVENT; LIFE STRESS; NEGATIVE FEEDBACK; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTRAUMA; REVIEW; SOCIAL PHOBIA;

ADULT; ANIMALS; ANXIETY DISORDERS; CHILD; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIFE CHANGE EVENTS; PITUITARY-ADRENAL SYSTEM; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84870199459     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803530907     Document Type: Review

References (196)

1. Blanchard DC, Blanchard RJ. Ethoexperimental approaches to the biology of emotion. Annu Rev Psychol 1988; 39: 43-68.
2. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936; 138 (1): 32.
3. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. Jama 1992; 267: 1244-52.
4. Graeff FG. Anxiety, panic and the hypothalamic-pituitary-adrenal axis. Rev Bras Psiquiatr 2007; 29: 3-6.
5. Vreeburg SA, Zitman FG, van Pelt J, et al. Salivary cortisol levels in persons with and without different anxiety disorders. Psychosom Med 2010; 72: 340-7.
6. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1-12.
7. Bandelow B, Späth C, Tichauer GA, Broocks A, Hajak G, Rüther E. Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder. Compr Psychiatry 2002; 43: 269-78.
8. Carpenter LL, Tyrka AR, Ross NS, Khoury L, Anderson GM, Price LH. Effect of childhood emotional abuse and age on cortisol responsivity in adulthood. Biol Psychiatry 2009; 66: 69-75.
9. Copeland WE, Keeler G, Angold A, Costello EJ. Traumatic events and posttraumatic stress in childhood. Arch Gen Psychiatry 2007; 64: 577-84.
10. Faravelli C, Gorini Amedei S, Rotella F, et al. Childhood traumata, Dexamethasone Suppression Test and psychiatric symptoms: a trans-diagnostic approach. Psychol Med 2010; 40: 2037-48.
11. Goodyer IM. Developmental psychopathology: the impact of recent life events in anxious and depressed school-age children. J R Soc Med 1994; 87: 327-9.
12. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 2001; 49: 1023-39.
13. Gibb BE, Chelminski I, Zimmerman M. Childhood emotional, physical, and sexual abuse, and diagnoses of depressive and anxiety disorders in adult psychiatric outpatients. Depress Anxiety 2007; 24: 256-63.
14. Nemeroff CB. The preeminent role of early untoward experience on vulnerability to major psychiatric disorders: The nature-nurture controversy revisited and soon to be resolved. Mol Pscyhiatry 1999; 4: 106-8.
15. Nemeroff CB. Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders. Psychopharmacol Bull 2004; 38: 14-20.
16. Safren SA, Gershuny BS, Marzol P, Otto MW, Pollack MH. History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder. J Nerv Ment Dis 2002; 190: 453-6.
17. Schoedl AF, Costa MC, Mari JJ, et al. The clinical correlates of reported childhood sexual abuse: an association between age at trauma onset and severity of depression and PTSD in adults. J Child Sex Abus 2010; 19: 156-70.
18. Stein MB, Walker JR, Anderson G, et al. Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample. Am J Psychiatry 1996; 153: 275-7.
19. Mancini C, Van-Ameringen M, Macmillan H. Relationship of childhood sexual and physical abuse to anxiety disorders. J Nerv Ment Dis 1995; 183: 309-14.
20. Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer-Verlag 1984.
21. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 1990; 15: 71-100.
22. Risbrough VB, Stein MB. Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav 2006; 50: 550-61.
23. Heim C, Newport DJ, Heit S, et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. Jama 2000; 284: 592-7.
24. Soravia LM, Heinrichs M, Aerni A, et al. Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci USA. 2006; 103: 5585-90.
25. Deakin JFW, Graeff FG. 5-HT and mechanisms of defense. J Psychopharmacol 1991; 5: 305-15.
26. Graeff FG, Garcia-Leal C, Del-Ben CM, Guimarães FS. Does the panic attack activate the hypothalamic-pituitary-adrenal axis? An Acad Bras Cienc 2005; 77: 477-91.
27. Henry, J. P. Biological basis of the stress response. Integrative Physiological & Behavioral Science 1992; 27: 66-83.
28. Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 2001; 158: 575-81.
29. Yehuda R, Flory JD, Pratchett LC, Buxbaum J, Ising M, Holsboer F. Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology 2010; 212: 405-17.
30. Yanos PT, Czaja SJ, Widom CS. A prospective examination of service use by abused and neglected children followed up into adulthood. Psychiatr Serv 2010; 61: 796-802.
31. Lang AJ, Aarons GA, Gearity J, et al. Direct and indirect links between childhood maltraeatment, posttraumatic stress disorder, and women's health. Behav Med 2008; 33: 125-35.
32. Pfeffer CR, Altemus M, Heo M, Jiang H. Salivary cortisol and psychopathology in children bereaved by the September 11, 2001 terror attacks. Biol Psychiatry 2007; 61: 957-65.
33. Tyrka AR, Wier L, Price LH, et al. Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biol Psychiatry 2008a; 63: 1147-54.
34. Charmandari E, Kino T, Souvatzoglou E, Chrousos GP. Pediatric stress: hormonal mediators and human development. Horm Res 2003; 59: 161-79.
35. Breier A, Kelsoe JR Jr, Kirwin PD, Beller SA, Wolkowitz OM, Pickar D. Early parental loss and development of adult psychopathology. Arch Gen Psychiatry 1988; 45: 987-93.
36. Bennett AJ, Lesch KP, Heils A, et al. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry 2002; 7:118-22.
37. Weller EB, Weller RA, Fristad MA, Bowes JM. Dexamethasone suppression test and depressive symptoms in bereaved children: a preliminary report. J Neuropsychiatry Clin Neurosci 1990; 2: 418-21.
38. Tyrka AR, Wier LM, Price LH, et al. Cortisol and ACTH responses to the Dex/CRH test: influence of temperament. Horm Behav 2008b; 53: 518-25.
39. Zohar J, Sonnino R, Juven-Wetzler A, Cohen H. Can posttraumatic stress disorder be prevented? CNS Spectr 2009; 14: 44-51.
40. Yehuda R, Antelman SM. Criteria for rationally evaluating animal models of posttraumatic stress disorder. Biol Psychiatry 1993a; 33: 479-86.
41. Seligman ME, Maier SF. Failure to escape traumatic shock. J Exp Psychol 1967; 74:1-9.
42. Porsolt RD. Animal model of depression. Biomedicine 1979; 30: 139-40.
43. Harlow HF, Harlow MK, Suomi SI. From thought to therapy: lessons from a primate laboratory. American Scientist 1971; 59: 538-49.
44. Katz RJ, Roth KA, Carrol B. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 1981; 5: 247-51.
45. Pryce CR, Rüedi-Bettschen D, Dettling AC, et al. Long-term effects of early-life environmental manipulations in rodents and primates: Potential animal models in depression research. Neurosci Biobehav Rev 2005; 29: 649-74.
46. Brenes Sáenz JC, Villagra OR, Fornaguera Trías J. Factor analysis of Forced Swimming test, Sucrose Preference test and Open Field test on enriched, social and isolated reared rats. Behav Brain Res 2006; 169:57-65.
47. Levine S, Johnson DF, Gonzalez CA. Behavioral and hormonal responses to separation in infant rhesus monkeys and mothers. Behav Neurosci 1985;99: 399-410.
48. Hennessy MB, Moorman L. Factors influencing cortisol and behavioral responses to maternal separation in guinea pigs. Behav Neurosci 1989; 103: 378-85.
49. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotrophin-releasing factor. Pharmacol Rev 1991; 43: 425-73.
50. Weiss JM, Stout JC, Aaron MF, et al. Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor. Brain Res Bull 1994; 35: 561-72.
51. Schreiber W, Lauer CJ, Krumrey K, Holsboer F, Krieg JC. Dysregulation of the hypothalamic-pituitaryadrenocortical system in panic disorder. Neuropsychopharmacology 1996; 15: 7-15.
52. Yehuda R, Halligan SL, Golier JA, Grossman R, Bierer LM. Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology 2004; 29: 389-404.
53. Condren RM, O'Neill A, Ryan MC, Barrett P, Thakore JH. HPA axis response to a psychological stressor in generalised social phobia. Psychoneuroendocrinology 2002; 27: 693-703.
54. Erhardt A, Ising M, Unschuld PG, et al. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology 2006; 31: 2515-22.
55. Abelson JL, Khan S, Liberzon I, Young EA. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety 2007; 24: 66-76.
56. Kallen VL, Tulen JH, Utens EM, Treffers PD, De Jong FH, Ferdinand RF. Associations between HPA axis functioning and level of anxiety in children and adolescents with an anxiety disorder. Depress Anxiety 2008; 25: 131-41.
57. Abelson JL, Curtis GC. Hypothalamic-pituitary-adrenal axis activity in panic disorder: 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 1996; 53: 323-31.
58. Bandelow B, Wedekind D, Pauls J, Broocks A, Hajak G, Rüther E. Salivary cortisol in panic attacks. Am J Psychiatry 2000; 157 (3): 454-6.
59. Brambilla F, Bellodi L, Perna G, et al. Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology 1992; 26: 12-22.
60. Chaudieu I, Beluche I, Norton J, Boulenger JP, Ritchie K, Ancelin ML. Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes. J Affect Disord 2008; 106: 307-13.
61. Mantella RC, Butters MA, Amico J.A, et al. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology 2008; 33: 773-81.
62. Gerra G, Zaimovic A, Zambelli U, et al. Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiology 2000; 42: 82-92.
63. van Veen JF, van Vliet IM, Derijk RH, van Pelt J, Mertens B, Zitman FG. Elevated alpha-amylase but not cortisol in generalized social anxiety disorder. Psychoneuroendocrinology 2008; 33: 1313-21.
64. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revised (DMS-IVTR). Washington DC: American Psychiatric Association 2000.
65. Sivik T, Delimar D, Korenjak P, Delimar N. The role of blood pressure, cortisol, and prolactine among soldiers injured in the 1991-1993 war in Croatia. Integr Physiol Behav Sci 1997; 32: 364-72.
66. Pynoos RS, Ritzmann RF, Steinberg AM, et al. A behavioral animal model of posttraumatic stress disorder featuring repeated exposure to situational reminders. Biol Psychiatry 1996; 39: 129-34.
67. Stam R, Bruijnzeel AW, Wiegant VM. Long-lasting stress sensitisation. Eur J Pharmacol 2000; 405:217-24.
68. Wang, J, Akirav I, Richter-Levin G. Short-term behavioral and electrophysiological consequences of underwater trauma. Physiol Behav 2000; 70: 327-32.
69. Adamec R, Kent P, Anisman H, Shallow T, Merali Z http://www.ncbi.nlm.nih.gov/pubmed?term=%22Anisman H%22%5BAuthor%5D. Neural plasticity, neuropeptides and anxiety in animals: implications for understanding and treating affective disorder following traumatic stress in humans. Neurosci Biobehav Rev 1998; 23: 301-18.
70. Adamec, RE, Burton P, Shallow T, Budgell J. NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure: implications for anxiety associated with posttraumatic stress disorder. Physiol Behav 1999; 65: 723-37.
71. Cohen, H, Zohar J, Matar M. The relevance of differential response to trauma in an animal model of post-traumatic stress disorder. Biol Psychiatry 2003; 15: 463-73.
72. Yehuda R, Resnick H, Kahuna B, Giller EL. Long-lasting hormonal alterations to extreme stress in humans: Normative or maladaptive? Psychosom Med 1993b; 55: 287-97.
73. Pervanidou P, Chrousos GP. Neuroendocrinology of post-traumatic stress disorder. Prog Brain Res 2010; 182: 149-60.
74. Lemieux AM, Coe CL. Abuse-related posstraumatic stress disorder: Evidence for chronic neurendocrine activation in women. Psychosom Med 1995; 57: 105-15.
75. De Bellis MD, Baum AS, Birmaher B, et al. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems. Biol Psychiatry 1999; 45: 1259-70.
76. Elzinga BM, Schmahl CG, Vermetten E, van Dyck R, Bremner JD. Higher cortisol levels following exposure to traumatic reminders in abuse related PTSD. Neuropsychopharmacology 2003; 28: 1656-65.
77. Rasmusson Ann M, Lipschitz DS, Wang S, et al. Increased Pituitary and Adrenal Reactivity in Premenopausal Women with Posttraumatic Stress Disorder. Biol Psychiatry 2001; 50: 965-77.
78. Stein MB, Yehuda R, Koverola C, Hanna C. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol Psychiatry 1997; 42: 680-6.
79. Newport DJ, Heim C, Bonsall R, Miller AH, Nemeroff CB. Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry 2004; 55: 10-20.
80. Jovanovic T, Norrholm SD, Blanding NQ, et al. Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD. Psychoneuroendocrinology 2010; 35: 846-57.
81. Altemus M, Cloitre M, Dhabhar FS. Enhanced cellular immune response in women with PTSD related to childhood abuse. Am J Psychiatry 2003; 160: 1705-7.
82. Lindley SE, Carlson EB, Benoit M. Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder. Biol Psychiatry 2004; 55: 940-5.
83. Bremner JD, Vythilingam M, Vermetten E, et al. Cortisol response to a cognitive stress challenge in posttraumatic stress disorder (PTSD) related to childhood abuse. Psychoneuroendocrinology 2003a; 28: 733-50.
84. Santa Ana EJ, Saladin ME, Back SE, et al. PTSD and the HPA axis: differences in response to the cold pressor task among indi viduals with child vs. adult trauma. Psychoneuroendocrinology 2006; 31(4): 501-9.
85. Mason J, Giller E, Kosten T. Urinary-free cortisol levels in posttraumatic stress disorder patients. Journal of Nervous and Mental Disorders 1986; 174: 145-59.
86. Meewisse ML, Reitsma JB, de Vries GJ, Gersons BP, Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br J Psychiatry 2007; 191: 387-92.
87. Rohleder N, Joksimovic L, Wolf JM, Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol Psychiatry 2004; 55: 745-51.
88. Yehuda R, Giller EL, Southwick S. Hypothalamic-pituitary-adrenal dysfunction in post-traumatic stress disorder. Biological Psychiatry 1991; 30: 1031-48.
89. Yehuda R, Kahana B, Binder-Brynes K. Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. American Journal of Psychiatry 1995b; 152: 982-86.
90. Wessa M, Rohleder N, Kirschbaum C, Flor H. Altered cortisol awakening response in posttraumatic stress disorder. Psychoneuroendocrinology 2006; 31: 209-15.
91. Smith MA, Davidson J, Ritchie JC, et al. The corticotropinreleasing hormone test in patients with posttraumatic stress disorder. Biol Psychiatry 1989; 26: 349-55.
92. Yehuda R, Boisoneau D, Lowy MT, Giller Jr EL. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 1995a; 52: 583-93.
93. McFarlane AC, Barton CA, Yehuda R, Wittert G. Cortisol response to acute trauma and risk of posttraumatic stress disorder. Psychoneuroendocrinology 2011; 36:720-7.
94. Yehuda R, Levengood RA, Schmeidler J, Wilson S, Guo LS, Gerber D. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology 1996; 21: 1-16.
95. Pitman R, Orr S. Twenty-four hour urinary cortisol and catecholamine excretion in combatrelated posttraumatic stress disorder. Biol. Psychiatry 1990; 27: 245-47.
96. Baker DG, West SA, Nicholson WE, et al. Serial CSF corticotrophin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 1999; 156: 585-88.
97. Bremner JD, Licinio J, Darnell A, et al. Elevated CSF corticotrophin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997; 154: 624-9.
98. Tucker P, Pfefferbaum B, North CS, Kent A, Jeon-Slaughter H, Parker DE. Biological correlates of direct exposure to terrorism several years postdisaster. Ann Clin Psychiatry. 2010; 22: 186-95.
99. Pfeffer CR, Altemus M, Heo M, Jiang H. Salivary cortisol and psychopathology in adults bereaved by the September 11, 2001 terror attacks. Int J Psychiatry Med 2009; 39: 215-26.
100. Liberzon I, Abelson JL, Flagel SB, Raz J, Young EA. Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology 1999; 21: 40-50.
101. Golier JA, Caramanica K, Yehuda R. Neuroendocrine response to CRF stimulation in veterans with and without PTSD in consideration of war zone era. Psychoneuroendocrinology. 2011 Aug 1. [Epub ahead of print]
102. Golier JA, Schmeidler J, Yehuda R. Pituitary response to metyrapone in Gulf War veterans: relationship to deployment, PTSD and unexplained health symptoms. Psychoneuroendocrinology 2009; 34: 1338-45.
103. Mason J, Wang S, Yehuda R, et al. Marked lability of urinary free cortisol levels in sub-groups of combat veterans with posttraumatic stress disorder. Psychosom Med 2002; 64: 238-46.
104. Kellner, M., Yassouridis, A., Hubner, R., Baker, D.G., Wiedemann, K. Endocrine and cardiovascular responses to corticotropinreleasing hormone in patients with posttraumatic stress disorder: a role for atrial natriuretic peptide? Neuropsychobiology 2003; 47: 102-8.
105. Young EA, Breslau N. Saliva cortisol in posttraumatic stress disorder: a community epidemiologic study. Biol Psychiatry 2004; 56: 205-9.
106. de Kloet C, Vermetten E, Lentjes E, et al. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder. Psychoneuroendocrinology 2008; 33: 313-20.
107. Yehuda R, Golier J, Harvey P. Neurobiological changes in elderly trauma survivors posttraumatic stress disorder. Journal of Clinical Psychiatry Cited from Biology of Posttraumatic Stress Disorder by Yehuda R. 1999; 61: 14-21.
108. Aardal-Eriksson E, Eriksson TE, Thorell LH. Salivary cortisol, posttraumatic stress symptoms, and general health in the acute phase and during 9-month follow-up. Biol Psychiatry 2001; 50: 986-93.
109. Shalev AY, Videlock EJ, Peleg T, Segman R, Pitman RK, Yehuda R. Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part I: HPA axis responses. Int J Neuropsychopharmacol 2008; 11: 365-72.
110. Nugent NR, Ostrowski S, Christopher NC, Delahanty DL. Parental posttraumatic stress symptoms as a moderator of child's acute biological response and subsequent posttraumatic stress symptoms in pediatric injury patients. J Pediatr Psychol 2007; 32: 309-18.
111. Yehuda R, Teicher MH, Seckl JR, Grossman RA, Morris A, Bierer LM. Parental posttraumatic stress disorder as a vulnerability factor for low cortisol trait in offspring of holocaust survivors. Arch Gen Psychiatry 2007; 64:1040-8.
112. Bremner JD, Vythilingam M, Vermetten E, et al. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry 2003b; 160: 924-32.
113. Joëls M, Krugers H, Karst H. Stress-induced changes in hippocampal function. Prog Brain Res 2008; 167: 3-15.
114. de Kloet CS, Vermetten E, Geuze E, Kavelaars A, Heijnen CJ, Westenberg HG. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res 2006; 40: 550-67.
115. Misslin R. The defense system of fear: behavior and neurocircuitry. Neurophysiologie Clinique 2003; 33: 55-66.
116. Blanchard DC, Griebel G, Blanchard RJ. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neuroscience and Biobehavioral Reviews 2001; 25: 205-18.
117. Jones N, Duxon MS, King SM. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents. Psychopharmacology 2002; 161: 314-32.
118. Graeff FG, Ferreira N.C, Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neuroscience and Biobehavioral Reviews 1998; 23: 237-46.
119. Lim LW, Blokland A, van Duinen M, et al. Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats. Behav Brain Res 2011; 218: 301-7.
120. Cameron OG, Lee MA, Curtis GC, McCann DS. Endocrine and physiological changes during "spontaneous" panic attacks. Psychoneuroendocrinology 1987; 12: 321-31.
121. Woods SW, Charney DS, McPherson CA, Gradman AH and Heninger GR. Situational panic attacks. Behavioral, physiologic, and biochemical characterization. Arch Gen Psychiatry 1987; 44: 365-75.
122. Schommer NC, Hellhammer DH, Kirschbaum C. Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress. Psychosom Med 2003; 65: 450-60.
123. 2 challenge induced HPA axis activation in panic. Int J Neuropsychopharmacol 2007; 10: 797-804
124. Klein DF. False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Archives of General Psychiatry 1993; 50: 306-17.
125. 2 vulnerability in panic disorder. Psychiatry Research 1987; 20: 87-95.
126. 2 and hyperventilation in patients with panic disorder. American Journal of Psychiatry 1994; 151: 547-53.
127. Gorman JM, Goetz RR, Dillon D, et al. SodiumD-lactate infusion of panic disorder patients. Neuropsychopharmacology 1990; 3: 181-90.
128. Gutman DA, Coplan J, Papp L, Martinez J, Gorman J. Doxapraminduced panic attacks and cortisol elevation. Psychiatry Research 2005; 133: 253-61.
129. Kathol RG, Anton R, Noyes R, Lopez AL, Reich JH. Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Res 1988; 24: 211-21.
130. Uhde T, Joffe RT, Jimerson DC, Post RM. Normal urinary free cortisol and plasma MHPG in panic disorder: Clinical and theoretical implications. Biol Psychiatry 1988; 23: 575-85.
131. Goldstein S, Halbreich U, Asnis G, Endicott J, Alvir J. The hypothalamic-pituitary-adrenal system in panic disorder. Am J Psychiatry 1987; 144: 1320-23.
132. Wedekind D, Bandelow B, Broocks A, Hajak G, Rüther E. Salivary, total plasma and plasma free cortisol in panic disorder. J Neural Transm 2000; 107: 831-7.
133. Coryell W, Noyes R, Reich J. The prognostic significance of HPAaxis disturbance in panic disorder: A three-year follow-up. Biol Psychiatry 1991; 29: 96-102.
134. Coryell W, Noyes R, Schlechte J. The significance of HPA axis disturbance in panic disorder. Biol Psychiatry 1989b; 25: 989-1002.
135. Lieberman JA, Brenner R, Lesser M, Coccaro E, Borenstein M, Kane JM. Dexamethasone suppression tests in patients with panic disorder. Am J Psychiatry 1983; 140: 917-19.
136. Petrowski K, Herold U, Joraschky P, Wittchen HU, Kirschbaum C. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses. Psychoneuroendocrinology 2010; 35: 414-21.
137. Kartalci S, Dogan M, Unal S, Ozcan AC, Ozdemir S, Atmaca M. Pituitary volume in patients with panic disorder. Prog NeuroPsychopharmacol Biol Psychiatry 2011; 35: 203-7.
138. Moitra E, Dyck I, Beard C, et al. Impact of stressful life events on the course of panic disorder in adults. J Affect Disord 2011; 134: 373-76.
139. 2 sensitivity: Effects of events occurring early in life. Am J Genet B Neuropsychatr Genet 2011; 156: 79-88.
140. Klauke B, Deckert J, Reif A, Pauli P, Domschke K. Life events in panic disorder-an update on candidate stressors. Depress Anxiety 2010; 27: 716-30.
141. Kar N, Bastia BK. Post-traumatic stress disorder, depression and generalised anxiety disorder in adolescents after a natural disaster: a study of comorbidity. Clin Pract Epidemol Ment Health 2006; 2-17.
142. Shore JH, Tatum EL, Vollmer WM. Psychiatric reactions to disaster: the Mount St. Helens experience. Am J Psychiatry 1986; 143: 590-95.
143. Gosselin P, Laberge B. Etiological factors of generalized anxiety disorder. Encephale 2003; 29: 351-61.
144. Kendler KS, Hettema JM, Butera F, Gardner CO, Prescott CA. Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch Gen Psychiatry 2003; 60: 789-96.
145. Nordahl HM, Wells A, Olsson CA, Bjerkeset O. Association between abnormal psychosocial situations in childhood, generalized anxiety disorder and oppositional defiant disorder. Aust N Z J Psychiatry 2010; 44: 852-8.
146. Schweizer EE, Swenson CM, Winokur A, Rickels K, Maislin G. The dexamethasone suppression test in generalised anxiety disorder. Br J Psychiatry 1986; 149: 320-22.
147. Tiller JW, Biddle N, Maguire KP, Davies BM. The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biol Psychiatry 1988; 23: 261-70.
148. Greaves-Lord K, Ferdinand RF, Oldehinkel AJ, Sondeijker FE, Ormel J, Verhulst FC. Higher cortisol awakening response in young adolescents with persistent anxiety problems. Acta Psychiatr Scand 2007; 116: 137-44.
149. Pomara N, Willoughby LM, Sidtis JJ, Cooper TB, Greenblatt DJ. Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder. Psychopharmacology (Berl) 2005; 178: 1-8.
150. Tafet GE, Feder DJ, Abulafia DP, Roffman SS. Regulation of hypothalamic-pituitary-adrenal activity in response to cognitive therapy in patients with generalized anxiety disorder. Cogn Affect Behav Neurosci 2005; 5: 37-40.
151. Roy-Byrne PP, Cowley DS, Hommer D, Ritchie J, Greenblatt D, Nemeroff C. Neuroendocrine effects of diazepam in panic and generalized anxiety disorders. Biol Psychiatry 1991; 30: 73-80.
152. Lenze EJ, Mantella RC, Shi P, et al. Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram. Am J Geriatr Psychiatry 2011; 19: 482-90.
153. Klein E, Zinder O, Colin V, Zilberman I, Levy N, Greenberg A, Lenox RH. Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder. Acta Psychiatr Scand 1995; 92: 399-408.
154. Rosenbaum AH, Schatzberg AF, Jost 3rd FA, et al. Urinary free cortisol levels in anxiety. Psychosom 1983; 24: 835-37.
155. Hoehn-Saric R, McLeod DR, Lee YB, Zimmerli WD. Cortisol levels in generalized anxiety disorder. Psychiatry Res 1991; 38: 313-15.
156. Steudte S, Stalder T, Dettenborn L, et al. Decreased hair cortisol concentrations in generalised anxiety disorder. Psychiatry Res 2011; 186: 310-4.
157. Kluge M, Schüssler P, Künzel HE, Dresler M, Yassouridis A, Steiger A. Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res 2007; 41: 928-33.
158. Findley DB, Leckman JF, Katsovich L, et al. Development of the Yale Children's Global Stress Index (YCGSI) and its application in children and adolescents with Tourette's syndrome and obsessivecompulsive disorder. J Am Acad Child Adolesc Psychiatry 2003; 42: 450-7.
159. Fineberg NA, Chamberlain SR, Hollander E, Boulougouris V, Robbins TW. Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment. Br J Pharmacol 2011; 164: 1044-61.
160. Cromer KR, Schmidt NB, Murphy DL. An investigation of traumatic life events and obsessive-compulsive disorder. Behav Res Ther 2007; 45: 1683-91.
161. Sarkhel S, Praharaj SK, Sinha VK.Role of life events in obsessive compulsive disorder. Isr J Psychiatry Relat Sci 2011; 48: 182-5.
162. Grabe HJ, Ruhrmann S, Spitzer C, et al. Obsessive-compulsive disorder and posttraumatic stress disorder. Psychopathology 2008; 41: 129-34.
163. Maina G, Albert U, Bogetto F, Vaschetto P, Ravizza L. Recent life events and obsessive-compulsive disorder (OCD): the role of pregnancy/ delivery. Psychiatry Res 1999; 89: 49-58.
164. Real E, Labad J, Alonso P, et al. Stressful life events at onset of obsessive-compulsive disorder are associated with a distinct clinical pattern. Depression and Anxiety 2011; 28: 367-76.
165. Monteleone P, Catapano F, Del Buono G, Maj M. Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 1994; 89: 411-15.
166. Altemus M, Pigott T, Kalogeras KT, et al. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 9-20.
167. Catapano F, Monteleone P, Maj M, Kemali D. Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls. Neuropsychobiology 1990; 23: 53-6.
168. Coryell WH, Black DW, Kelly MW, Noyes R Jr. HPA axis disturbance in obsessive-compulsive disorder. Psychiatry Res 1989a; 30: 243-51.
169. Lord C, Steiner M, Soares CN, Carew CL, Hall GB. Stress response in postpartum women with and without obsessive-compulsive symptoms: an fMRI study. J Psychiatry Neurosci 2011; 36: 110005.
170. Ursu S, Stenger VA, Shear MK, Jones MR, Carter CS. Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychol Sci 2003; 14: 347-53.
171. Potts NL, Davidson JR, Krishnan KR, Doraiswamy PM, Ritchie JC. Levels of urinary free cortisol in social phobia. J Clin Psychiatry 1991; 52: 41-2.
172. Uhde TW, Tancer ME, Gelernter CS, Vittone BJ. Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers. J Affect Disord 1994; 30: 155-61.
173. Lanzenberger R, Wadsak W, Spindelegger C, et al. Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. Int J Neuropsychopharmacol 2010; 13: 1129-43.
174. Roelofs K, van Peer J, Berretty E, Jong P, Spinhoven P, Elzinga BM. Hypothalamus-pituitary-adrenal axis hyperresponsiveness is associated with increased social avoidance behavior in social phobia. Biol Psychiatry 2009; 65: 336-43.
175. Levin AP, Saoud JB, Strauman T, et al. Responses of "generalized" and "discrete" social phobics during public speaking. J Anxiety Disord 1993; 7: 207-21.
176. Furlan PM, DeMartinis N, Schweizer E, Rickels K, Lucki I. Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress. Biol Psychiatry 2001; 50: 254-9.
177. Martel FL, Hayward C, Lyons DM, Sanborn K, Varady S, Schatzberg AF. Salivary cortisol levels in socially phobic adolescent girls. Depress Anxiety 1999; 10: 25-7.
178. van West D, Claes S, Sulon J, Deboutte D. Hypothalamic-pituitaryadrenal reactivity in prepubertal children with social phobia. J Affect Disord 2008; 111: 281-90.
179. Krämer M, Seefeldt WL, Heinrichs N, et al. Subjective, Autonomic, and Endocrine Reactivity during Social Stress in Children with Social Phobia. J Abnorm Child Psychol 2011 Jul 29. [Epub ahead of print]
180. Russ SJ, Herbert J, Cooper P, et al. Cortisol levels in response to starting school in children at increased risk for social phobia. Psychoneuroendocrinology. 2011 Aug 16. [Epub ahead of print]
181. Rettew DC. Avoidant personality disorder, generalized social phobia, and shyness: putting the personality back into personality disorders. Harv Rev Psychiatry 2000; 8: 283-97.
182. Schmidt LA, Fox NA, Rubin KH, et al. Behavioral and neuroendocrine responses in shy children. Dev Psychobiol 1997; 30: 127-40.
183. Brand S, Wilhelm FH, Kossowsky J, Holsboer-Trachsler E, Schneider S. Children suffering from separation anxiety disorder (SAD) show increased HPA axis activity compared to healthy controls. J Psychiatr Res 2011; 45: 452-9.
184. Kagan J, Reznick JS, Snidman N. Biological bases of childhood shyness. Science 1988; 240: 167-71.
185. Núñez JF, Ferré P, Escorihuela RM, Tobeña A, Fernández-Teruel A. Effects of postnatal handling of rats on emotional, HPA-axis, and prolactin reactivity to novelty and conflict. Physiol Behav 1996; 60: 1355-9.
186. Cavigelli SA, Stine MM, Kovacsics C, Jefferson A, Diep MN, Barrett CE. Behavioral inhibition and glucocorticoid dynamics in a rodent model. Physiol Behav 2007; 92: 897-905.
187. Erwin BA, Heimberg RG, Marx BP, Franklin ME. Traumatic and socially stressful life events among persons with social anxiety disorder. J Anxiety Disord 2006; 20: 896-914.
188. Carleton RN, Peluso DL, Collimore KC, Asmundson GJ. Social anxiety and posttraumatic stress symptoms: the impact of distressing social events. J Anxiety Disord 2011; 25: 49-57.
189. Bandelow B, Charimo Torrente A, Wedekind D, Broocks A, Hajak G, Rüther E. Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder. Eur Arch Psychiatry Clin Neurosci 2004; 254: 397-405.
190. Simon NM, Herlands NN, Marks EH, et al. Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorder. Depress Anxiety 2009; 26: 1027-32.
191. Elzinga BM, Spinhoven P, Berretty E, de Jong P, Roelofs K. The role of childhood abuse in HPA-axis reactivity in Social Anxiety Disorder: a pilot study. Biol Psychol 2010; 83: 1-6.
192. Brook CA, Schmidt LA. Social anxiety disorder: a review of environmental risk factors. Neuropsychiatr Dis Treat 2008; 4: 123-43.
193. Rapee RM, Spence SH. The etiology of social phobia: empirical evidence and an initial model. Clin Psychol Rev 2004; 24: 737-67.
194. Meaney MJ, Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 2005; 7:103-23.
195. Weaver IC, Meaney MJ, Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 2006; 10: 3480-85.
196. Szyf M, Weaver IC, Champagne FA, Diorio J, Meaney MJ. Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Front Neuroendocrinol. 2005;26(3-4):139-62